The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,4R)-1-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide ID: ALA4228963
PubChem CID: 145986800
Max Phase: Preclinical
Molecular Formula: C24H29F3N4O4S
Molecular Weight: 526.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C(F)(F)F)C(C)(C)C)cc1
Standard InChI: InChI=1S/C24H29F3N4O4S/c1-13-18(36-12-29-13)15-7-5-14(6-8-15)10-28-20(33)17-9-16(32)11-31(17)21(34)19(23(2,3)4)30-22(35)24(25,26)27/h5-8,12,16-17,19,32H,9-11H2,1-4H3,(H,28,33)(H,30,35)/t16-,17+,19-/m1/s1
Standard InChI Key: LDFHQQVQPPLUDX-ZIFCJYIRSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
3.6042 -24.8627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8917 -24.4502 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.8907 -25.2735 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.7458 -23.6252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4625 -23.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7506 -22.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4625 -24.8627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1770 -24.4502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7480 -24.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4625 -25.6877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9305 -24.7806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4825 -24.1675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0700 -23.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2631 -23.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1043 -25.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4928 -26.1409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8896 -25.8398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0634 -26.6464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8488 -26.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0206 -27.7039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8051 -27.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4176 -27.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2404 -26.5927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4561 -26.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2033 -27.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4605 -28.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2855 -28.4312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5372 -27.6454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8678 -27.1634 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.9785 -29.1041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0336 -24.8627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4055 -22.6993 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3191 -24.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3191 -23.6252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0336 -23.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6046 -25.6877 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
5 4 1 0
4 6 1 0
7 8 1 0
7 9 1 0
7 10 2 0
8 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 8 1 0
11 15 1 1
15 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 25 1 0
26 30 1 0
9 4 1 1
9 31 1 0
13 32 1 6
31 33 1 0
33 34 2 0
4 35 1 0
33 1 1 0
1 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 526.58Molecular Weight (Monoisotopic): 526.1862AlogP: 2.79#Rotatable Bonds: 6Polar Surface Area: 111.63Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.12CX Basic pKa: 2.65CX LogP: 1.80CX LogD: 1.42Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.54Np Likeness Score: -0.58
References 1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A.. (2018) Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)., 61 (2): [PMID:28853884 ] [10.1021/acs.jmedchem.7b00675 ]